BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

605 related articles for article (PubMed ID: 27696099)

  • 1. Utilization of osteoporosis medication after a fragility fracture among elderly Medicare beneficiaries.
    Yusuf AA; Matlon TJ; Grauer A; Barron R; Chandler D; Peng Y
    Arch Osteoporos; 2016 Dec; 11(1):31. PubMed ID: 27696099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Examining the Effect of Medication Adherence on Risk of Subsequent Fracture Among Women with a Fragility Fracture in the U.S. Medicare Population.
    Keshishian A; Boytsov N; Burge R; Krohn K; Lombard L; Zhang X; Xie L; Baser O
    J Manag Care Spec Pharm; 2017 Nov; 23(11):1178-1190. PubMed ID: 29083977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Examining the treatment gap and risk of subsequent fractures among females with a fragility fracture in the US Medicare population.
    Keshishian A; Boytsov N; Burge R; Krohn K; Lombard L; Zhang X; Xie L; Baser O
    Osteoporos Int; 2017 Aug; 28(8):2485-2494. PubMed ID: 28536737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of bone protection and associated fragility injuries in patients with proximal femur fractures.
    Aguado-Maestro I; Panteli M; García-Alonso M; Bañuelos-Díaz A; Giannoudis PV
    Injury; 2017 Dec; 48 Suppl 7():S27-S33. PubMed ID: 28851521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Declining rates of osteoporosis management following fragility fractures in the U.S., 2000 through 2009.
    Balasubramanian A; Tosi LL; Lane JM; Dirschl DR; Ho PR; O'Malley CD
    J Bone Joint Surg Am; 2014 Apr; 96(7):e52. PubMed ID: 24695929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medication persistence and risk of fracture among female Medicare beneficiaries diagnosed with osteoporosis.
    Liu J; Guo H; Rai P; Pinto L; Barron R
    Osteoporos Int; 2018 Nov; 29(11):2409-2417. PubMed ID: 30022254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Declining trend in osteoporosis management and screening following vertebral compression fractures - a national analysis of commercial insurance and medicare advantage beneficiaries.
    Malik AT; Retchin S; Phillips FM; Xu W; Peters K; Yu E; Khan SN
    Spine J; 2020 Apr; 20(4):538-546. PubMed ID: 31683068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-fracture pharmacotherapy for women with osteoporotic fracture: analysis of a managed care population in the USA.
    Wilk A; Sajjan S; Modi A; Fan CP; Mavros P
    Osteoporos Int; 2014 Dec; 25(12):2777-86. PubMed ID: 25112720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disparities in osteoporosis treatments.
    Liu Z; Weaver J; de Papp A; Li Z; Martin J; Allen K; Hui S; Imel EA
    Osteoporos Int; 2016 Feb; 27(2):509-19. PubMed ID: 26216226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hip and other fragility fracture incidence in real-world teriparatide-treated patients in the United States.
    Burge RT; Disch DP; Gelwicks S; Zhang X; Krege JH
    Osteoporos Int; 2017 Mar; 28(3):799-809. PubMed ID: 28028555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of Prescription Drug Use Before and After Fragility Fracture.
    Munson JC; Bynum JP; Bell JE; Cantu R; McDonough C; Wang Q; Tosteson TD; Tosteson AN
    JAMA Intern Med; 2016 Oct; 176(10):1531-1538. PubMed ID: 27548843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-osteoporosis medication treatment pattern after osteoporotic fracture during 2010-2016 in Fujian, China.
    Wang X; Li C; He Y; Wang T; Zhang H; Ma Z; Ma H; Zhao H
    Arch Osteoporos; 2020 Aug; 15(1):134. PubMed ID: 32820451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoporosis in the Women's Health Initiative: Another Treatment Gap?
    Sattari M; Cauley JA; Garvan C; Johnson KC; LaMonte MJ; Li W; Limacher M; Manini T; Sarto GE; Sullivan SD; Wactawski-Wende J; Beyth RJ
    Am J Med; 2017 Aug; 130(8):937-948. PubMed ID: 28366425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Osteoporosis Medications Associated with Decreased Mortality after Hip Fracture.
    Wang PW; Li YZ; Zhuang HF; Yu HM; Cai SQ; Xu H; Chen ZH; Lin JK; Yao XD
    Orthop Surg; 2019 Oct; 11(5):777-783. PubMed ID: 31429532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The near absence of osteoporosis treatment in older men with fractures.
    Feldstein AC; Nichols G; Orwoll E; Elmer PJ; Smith DH; Herson M; Aickin M
    Osteoporos Int; 2005 Aug; 16(8):953-62. PubMed ID: 15928798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A survey of outcomes and management of patients post fragility fractures in China.
    Wang O; Hu Y; Gong S; Xue Q; Deng Z; Wang L; Liu H; Tang H; Guo X; Chen J; Jia X; Xu Y; Lan L; Lei C; Dong H; Yuan G; Fu Q; Wei Y; Xia W; Xu L
    Osteoporos Int; 2015 Nov; 26(11):2631-40. PubMed ID: 25966892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of anti-osteoporosis medication dispensing by patients with hip fracture: could we do better?
    Kristensen PK; Ehrenstein V; Shetty N; Pedersen AB
    Osteoporos Int; 2019 Sep; 30(9):1817-1825. PubMed ID: 31263921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in anti-osteoporotic medication utilization following fragility fracture in the USA from 2011 to 2019.
    Agarwal AR; Cohen JS; Jorgensen A; Thakkar SC; Srikumaran U; Golladay GJ
    Osteoporos Int; 2023 Feb; 34(2):379-385. PubMed ID: 36462054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Osteoporosis Medication Use After Hip Fracture With Prevention of Subsequent Nonvertebral Fractures: An Instrumental Variable Analysis.
    Desai RJ; Mahesri M; Abdia Y; Barberio J; Tong A; Zhang D; Mavros P; Kim SC; Franklin JM
    JAMA Netw Open; 2018 Jul; 1(3):e180826. PubMed ID: 30646034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients with prior vertebral or hip fractures treated with teriparatide in the Direct Assessment of Nonvertebral Fractures in Community Experience (DANCE) observational study.
    Beall DP; Feldman RG; Gordon ML; Gruber BL; Lane JM; Valenzuela G; Yim D; Alam J; Krege JH; Krohn K
    Osteoporos Int; 2016 Mar; 27(3):1191-1198. PubMed ID: 26556737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.